Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?
نویسندگان
چکیده
منابع مشابه
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes
PURPOSE To analyse early toxicity of high-dose-rate brachytherapy (HDRB) boost for prostate cancer using 3 fractionation schemes. MATERIAL AND METHODS From February 2009 to May 2012, after the first course of external beam radiation therapy (EBRT 46 Gy/23 f), 124 patients underwent HDRB boost for low (7%), intermediate (19%), and high-risk (73%) prostate cancers. From February to December 200...
متن کاملHigh-dose statins should only be used in atherosclerotic strokes.
Statin therapy should not be initiated in this patient, a young woman free of vascular risk factors and at low risk for atherosclerotic cerebrovascular disease. Unfortunately, this patient has an iatrogenic stroke after a cardiac catheterization performed for symptoms described as “atypical.” There is no evidence that underlying atherosclerotic disease accounted for her cardiac symptoms or stro...
متن کاملFractionated High-Dose-Rate Brachytherapy
Purpose: A growing body of data suggests that local control in nasopharyngeal cancer (NPC) is related to the radiation dose administered. We conducted a singleinstitution study of high-dose radiotherapy (RT), which incorporated high-dose-rate (HDR) brachytherapy (BT). These results were analyzed together with data obtained from controls who did not receive BT. Patients and Methods: The BT group...
متن کاملBrachytherapy boost for T1/T2 nasopharyngeal carcinoma.
BACKGROUND The aim of this study was to review our experience and demonstrate the safety of intracavitary brachytherapy (ICB) in patients with nasopharyngeal carcinoma (NPC). METHODS Hundred seventy-eight patients with early T1-2b disease underwent radical external beam radiation therapy (EBRT) followed by ICB boost. The primary tumor received 66 Gy of EBRT over 33 fractions using 6 or 10 MV ...
متن کاملLong-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer
Purpose To evaluate long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer. Material and methods Seventy-three patients with clinically staged T1/T2 N0 M0 of mobile tongue cancer were studied retrospectively. Between January 2000 and September 2010, 47 patients underwent high-dose-rate brachytherapy (HDR-BT) alone and 26 patients underw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reports of Practical Oncology & Radiotherapy
سال: 2020
ISSN: 1507-1367
DOI: 10.1016/j.rpor.2020.04.001